Controversial US-Backed Vaccination Study Begins in Guinea-Bissau 07/01/2026 Kerry Cullinan A US government-funded trial on the timing of hepatitis B vaccinations, which will delay vaccination for up to 7,000 newborns in Guinea-Bissau, started this week. The US Centers for Disease Control and Prevention (CDC) has awarded a controversial Danish research group a $1,6 million five-year grant to study the “optimal timing and delivery of monovalent […] Continue reading -> US EPA dismisses WHO Cancer Agency Determination that Widely Used Herbicide is ‘Probably Carcinogenic’ 05/01/2026 Sophia Samantaroy The US Environmental Protection Agency has dismissed a recent finding that atrazine, the second most widely-used herbicide in the United States, is “probably carcinogenic to humans” by the World Health Organization’s cancer review agency. Atrazine is used extensively in the US on crops like corn, sorghum, and sugarcane. However, over 60 countries have banned the […] Continue reading -> WHO Issues First-Ever Guidelines for GLP-1 Drugs – Including Obesity 04/12/2025 Sophia Samantaroy First-ever WHO guidelines recommending the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults has been issued by the World Health Organization – in what the global health agency said is a “conditional” sign of approval for the cutting edge medications that have become widely popular. The new WHO recommendations go […] Continue reading -> ‘Unprecedented Levels of Industry Interference’ Stalls Decisions on New Tobacco Products and Pollution at UNFCTC COP11 22/11/2025 Felix Sassmannshausen The Eleventh Conference of the Parties (COP) to the WHO Framework Convention on Tobacco Control (FCTC) concluded in Geneva on Saturday with calls to member states to take stronger action on reducing the environmental harm of tobacco use and increasing corporate liability. But political stand-offs between countries, along with industry interference, hindered major breakthroughs on […] Continue reading -> Air Pollution-Related Dementia Kills Over 625,000 People A Year 23/10/2025 Chetan Bhattacharji From killing over 600,000 elderly from dementia to an almost equal number of infants under the age of one-year, air pollution’s impact on young and old is explained simply through hard-hitting numbers in the latest State of Global Air (SOGA) report, by the Boston-based Health Effects Institute. The report identifies plenty of scope for immediate […] Continue reading -> Global Life Expectancy Sees Post-COVID Rebound – But Deaths Among Youths In North America and Latin America Rise 13/10/2025 Elaine Ruth Fletcher BERLIN – Global life expectancy rose again in 2023 after a decline during the COVID pandemic with overall life expectancy 20 years higher as compared to 1950. But North America and Latin America are seeing higher death rates among adolescents and young adults due to a crisis in mental health – reflected in higher rates […] Continue reading -> ‘Mismatch’ in the Air – Experts Call for Lung Health to be a Priority in Tackling Chronic Diseases 26/09/2025 Raisa Santos NEW YORK – Although chronic respiratory diseases (CRDs) are the third leading cause of death globally, there remains a ‘mismatch’ between impact and action, said a group of global health leaders and experts on the sidelines of the 80th UN General Assembly. “There is a mismatch between the disease [impact] from CRD and the action against […] Continue reading -> UN Declaration on Noncommunicable Diseases Fails to Win Approval After US Foils Consensus 25/09/2025 Elaine Ruth Fletcher NEW YORK CITY – A painstakingly negotiated Political Declaration on Noncommunicable Diseases with overwhelming support from UN member states failed to win formal endorsement at a special High Level Session of the General Assembly (GA) Thursday – after the United States torpedoed its adoption by consensus. The last minute moves means that the draft declaration […] Continue reading -> A Problem Shared Is a Problem Halved: Why Cities Are Essential for Confronting the NCD Crisis 22/09/2025 Ariella Rojhani & Etienne Krug On 25 September, world leaders will gather at the United Nations for the Fourth High-Level Meeting on Noncommunicable Diseases (NCDs). It comes at a pivotal moment: funding for global health has plummeted, while NCDs like heart disease, cancer and diabetes continue to claim 75% of all lives lost worldwide. This amid recent efforts to water […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US EPA dismisses WHO Cancer Agency Determination that Widely Used Herbicide is ‘Probably Carcinogenic’ 05/01/2026 Sophia Samantaroy The US Environmental Protection Agency has dismissed a recent finding that atrazine, the second most widely-used herbicide in the United States, is “probably carcinogenic to humans” by the World Health Organization’s cancer review agency. Atrazine is used extensively in the US on crops like corn, sorghum, and sugarcane. However, over 60 countries have banned the […] Continue reading -> WHO Issues First-Ever Guidelines for GLP-1 Drugs – Including Obesity 04/12/2025 Sophia Samantaroy First-ever WHO guidelines recommending the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults has been issued by the World Health Organization – in what the global health agency said is a “conditional” sign of approval for the cutting edge medications that have become widely popular. The new WHO recommendations go […] Continue reading -> ‘Unprecedented Levels of Industry Interference’ Stalls Decisions on New Tobacco Products and Pollution at UNFCTC COP11 22/11/2025 Felix Sassmannshausen The Eleventh Conference of the Parties (COP) to the WHO Framework Convention on Tobacco Control (FCTC) concluded in Geneva on Saturday with calls to member states to take stronger action on reducing the environmental harm of tobacco use and increasing corporate liability. But political stand-offs between countries, along with industry interference, hindered major breakthroughs on […] Continue reading -> Air Pollution-Related Dementia Kills Over 625,000 People A Year 23/10/2025 Chetan Bhattacharji From killing over 600,000 elderly from dementia to an almost equal number of infants under the age of one-year, air pollution’s impact on young and old is explained simply through hard-hitting numbers in the latest State of Global Air (SOGA) report, by the Boston-based Health Effects Institute. The report identifies plenty of scope for immediate […] Continue reading -> Global Life Expectancy Sees Post-COVID Rebound – But Deaths Among Youths In North America and Latin America Rise 13/10/2025 Elaine Ruth Fletcher BERLIN – Global life expectancy rose again in 2023 after a decline during the COVID pandemic with overall life expectancy 20 years higher as compared to 1950. But North America and Latin America are seeing higher death rates among adolescents and young adults due to a crisis in mental health – reflected in higher rates […] Continue reading -> ‘Mismatch’ in the Air – Experts Call for Lung Health to be a Priority in Tackling Chronic Diseases 26/09/2025 Raisa Santos NEW YORK – Although chronic respiratory diseases (CRDs) are the third leading cause of death globally, there remains a ‘mismatch’ between impact and action, said a group of global health leaders and experts on the sidelines of the 80th UN General Assembly. “There is a mismatch between the disease [impact] from CRD and the action against […] Continue reading -> UN Declaration on Noncommunicable Diseases Fails to Win Approval After US Foils Consensus 25/09/2025 Elaine Ruth Fletcher NEW YORK CITY – A painstakingly negotiated Political Declaration on Noncommunicable Diseases with overwhelming support from UN member states failed to win formal endorsement at a special High Level Session of the General Assembly (GA) Thursday – after the United States torpedoed its adoption by consensus. The last minute moves means that the draft declaration […] Continue reading -> A Problem Shared Is a Problem Halved: Why Cities Are Essential for Confronting the NCD Crisis 22/09/2025 Ariella Rojhani & Etienne Krug On 25 September, world leaders will gather at the United Nations for the Fourth High-Level Meeting on Noncommunicable Diseases (NCDs). It comes at a pivotal moment: funding for global health has plummeted, while NCDs like heart disease, cancer and diabetes continue to claim 75% of all lives lost worldwide. This amid recent efforts to water […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Issues First-Ever Guidelines for GLP-1 Drugs – Including Obesity 04/12/2025 Sophia Samantaroy First-ever WHO guidelines recommending the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults has been issued by the World Health Organization – in what the global health agency said is a “conditional” sign of approval for the cutting edge medications that have become widely popular. The new WHO recommendations go […] Continue reading -> ‘Unprecedented Levels of Industry Interference’ Stalls Decisions on New Tobacco Products and Pollution at UNFCTC COP11 22/11/2025 Felix Sassmannshausen The Eleventh Conference of the Parties (COP) to the WHO Framework Convention on Tobacco Control (FCTC) concluded in Geneva on Saturday with calls to member states to take stronger action on reducing the environmental harm of tobacco use and increasing corporate liability. But political stand-offs between countries, along with industry interference, hindered major breakthroughs on […] Continue reading -> Air Pollution-Related Dementia Kills Over 625,000 People A Year 23/10/2025 Chetan Bhattacharji From killing over 600,000 elderly from dementia to an almost equal number of infants under the age of one-year, air pollution’s impact on young and old is explained simply through hard-hitting numbers in the latest State of Global Air (SOGA) report, by the Boston-based Health Effects Institute. The report identifies plenty of scope for immediate […] Continue reading -> Global Life Expectancy Sees Post-COVID Rebound – But Deaths Among Youths In North America and Latin America Rise 13/10/2025 Elaine Ruth Fletcher BERLIN – Global life expectancy rose again in 2023 after a decline during the COVID pandemic with overall life expectancy 20 years higher as compared to 1950. But North America and Latin America are seeing higher death rates among adolescents and young adults due to a crisis in mental health – reflected in higher rates […] Continue reading -> ‘Mismatch’ in the Air – Experts Call for Lung Health to be a Priority in Tackling Chronic Diseases 26/09/2025 Raisa Santos NEW YORK – Although chronic respiratory diseases (CRDs) are the third leading cause of death globally, there remains a ‘mismatch’ between impact and action, said a group of global health leaders and experts on the sidelines of the 80th UN General Assembly. “There is a mismatch between the disease [impact] from CRD and the action against […] Continue reading -> UN Declaration on Noncommunicable Diseases Fails to Win Approval After US Foils Consensus 25/09/2025 Elaine Ruth Fletcher NEW YORK CITY – A painstakingly negotiated Political Declaration on Noncommunicable Diseases with overwhelming support from UN member states failed to win formal endorsement at a special High Level Session of the General Assembly (GA) Thursday – after the United States torpedoed its adoption by consensus. The last minute moves means that the draft declaration […] Continue reading -> A Problem Shared Is a Problem Halved: Why Cities Are Essential for Confronting the NCD Crisis 22/09/2025 Ariella Rojhani & Etienne Krug On 25 September, world leaders will gather at the United Nations for the Fourth High-Level Meeting on Noncommunicable Diseases (NCDs). It comes at a pivotal moment: funding for global health has plummeted, while NCDs like heart disease, cancer and diabetes continue to claim 75% of all lives lost worldwide. This amid recent efforts to water […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘Unprecedented Levels of Industry Interference’ Stalls Decisions on New Tobacco Products and Pollution at UNFCTC COP11 22/11/2025 Felix Sassmannshausen The Eleventh Conference of the Parties (COP) to the WHO Framework Convention on Tobacco Control (FCTC) concluded in Geneva on Saturday with calls to member states to take stronger action on reducing the environmental harm of tobacco use and increasing corporate liability. But political stand-offs between countries, along with industry interference, hindered major breakthroughs on […] Continue reading -> Air Pollution-Related Dementia Kills Over 625,000 People A Year 23/10/2025 Chetan Bhattacharji From killing over 600,000 elderly from dementia to an almost equal number of infants under the age of one-year, air pollution’s impact on young and old is explained simply through hard-hitting numbers in the latest State of Global Air (SOGA) report, by the Boston-based Health Effects Institute. The report identifies plenty of scope for immediate […] Continue reading -> Global Life Expectancy Sees Post-COVID Rebound – But Deaths Among Youths In North America and Latin America Rise 13/10/2025 Elaine Ruth Fletcher BERLIN – Global life expectancy rose again in 2023 after a decline during the COVID pandemic with overall life expectancy 20 years higher as compared to 1950. But North America and Latin America are seeing higher death rates among adolescents and young adults due to a crisis in mental health – reflected in higher rates […] Continue reading -> ‘Mismatch’ in the Air – Experts Call for Lung Health to be a Priority in Tackling Chronic Diseases 26/09/2025 Raisa Santos NEW YORK – Although chronic respiratory diseases (CRDs) are the third leading cause of death globally, there remains a ‘mismatch’ between impact and action, said a group of global health leaders and experts on the sidelines of the 80th UN General Assembly. “There is a mismatch between the disease [impact] from CRD and the action against […] Continue reading -> UN Declaration on Noncommunicable Diseases Fails to Win Approval After US Foils Consensus 25/09/2025 Elaine Ruth Fletcher NEW YORK CITY – A painstakingly negotiated Political Declaration on Noncommunicable Diseases with overwhelming support from UN member states failed to win formal endorsement at a special High Level Session of the General Assembly (GA) Thursday – after the United States torpedoed its adoption by consensus. The last minute moves means that the draft declaration […] Continue reading -> A Problem Shared Is a Problem Halved: Why Cities Are Essential for Confronting the NCD Crisis 22/09/2025 Ariella Rojhani & Etienne Krug On 25 September, world leaders will gather at the United Nations for the Fourth High-Level Meeting on Noncommunicable Diseases (NCDs). It comes at a pivotal moment: funding for global health has plummeted, while NCDs like heart disease, cancer and diabetes continue to claim 75% of all lives lost worldwide. This amid recent efforts to water […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Air Pollution-Related Dementia Kills Over 625,000 People A Year 23/10/2025 Chetan Bhattacharji From killing over 600,000 elderly from dementia to an almost equal number of infants under the age of one-year, air pollution’s impact on young and old is explained simply through hard-hitting numbers in the latest State of Global Air (SOGA) report, by the Boston-based Health Effects Institute. The report identifies plenty of scope for immediate […] Continue reading -> Global Life Expectancy Sees Post-COVID Rebound – But Deaths Among Youths In North America and Latin America Rise 13/10/2025 Elaine Ruth Fletcher BERLIN – Global life expectancy rose again in 2023 after a decline during the COVID pandemic with overall life expectancy 20 years higher as compared to 1950. But North America and Latin America are seeing higher death rates among adolescents and young adults due to a crisis in mental health – reflected in higher rates […] Continue reading -> ‘Mismatch’ in the Air – Experts Call for Lung Health to be a Priority in Tackling Chronic Diseases 26/09/2025 Raisa Santos NEW YORK – Although chronic respiratory diseases (CRDs) are the third leading cause of death globally, there remains a ‘mismatch’ between impact and action, said a group of global health leaders and experts on the sidelines of the 80th UN General Assembly. “There is a mismatch between the disease [impact] from CRD and the action against […] Continue reading -> UN Declaration on Noncommunicable Diseases Fails to Win Approval After US Foils Consensus 25/09/2025 Elaine Ruth Fletcher NEW YORK CITY – A painstakingly negotiated Political Declaration on Noncommunicable Diseases with overwhelming support from UN member states failed to win formal endorsement at a special High Level Session of the General Assembly (GA) Thursday – after the United States torpedoed its adoption by consensus. The last minute moves means that the draft declaration […] Continue reading -> A Problem Shared Is a Problem Halved: Why Cities Are Essential for Confronting the NCD Crisis 22/09/2025 Ariella Rojhani & Etienne Krug On 25 September, world leaders will gather at the United Nations for the Fourth High-Level Meeting on Noncommunicable Diseases (NCDs). It comes at a pivotal moment: funding for global health has plummeted, while NCDs like heart disease, cancer and diabetes continue to claim 75% of all lives lost worldwide. This amid recent efforts to water […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Life Expectancy Sees Post-COVID Rebound – But Deaths Among Youths In North America and Latin America Rise 13/10/2025 Elaine Ruth Fletcher BERLIN – Global life expectancy rose again in 2023 after a decline during the COVID pandemic with overall life expectancy 20 years higher as compared to 1950. But North America and Latin America are seeing higher death rates among adolescents and young adults due to a crisis in mental health – reflected in higher rates […] Continue reading -> ‘Mismatch’ in the Air – Experts Call for Lung Health to be a Priority in Tackling Chronic Diseases 26/09/2025 Raisa Santos NEW YORK – Although chronic respiratory diseases (CRDs) are the third leading cause of death globally, there remains a ‘mismatch’ between impact and action, said a group of global health leaders and experts on the sidelines of the 80th UN General Assembly. “There is a mismatch between the disease [impact] from CRD and the action against […] Continue reading -> UN Declaration on Noncommunicable Diseases Fails to Win Approval After US Foils Consensus 25/09/2025 Elaine Ruth Fletcher NEW YORK CITY – A painstakingly negotiated Political Declaration on Noncommunicable Diseases with overwhelming support from UN member states failed to win formal endorsement at a special High Level Session of the General Assembly (GA) Thursday – after the United States torpedoed its adoption by consensus. The last minute moves means that the draft declaration […] Continue reading -> A Problem Shared Is a Problem Halved: Why Cities Are Essential for Confronting the NCD Crisis 22/09/2025 Ariella Rojhani & Etienne Krug On 25 September, world leaders will gather at the United Nations for the Fourth High-Level Meeting on Noncommunicable Diseases (NCDs). It comes at a pivotal moment: funding for global health has plummeted, while NCDs like heart disease, cancer and diabetes continue to claim 75% of all lives lost worldwide. This amid recent efforts to water […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘Mismatch’ in the Air – Experts Call for Lung Health to be a Priority in Tackling Chronic Diseases 26/09/2025 Raisa Santos NEW YORK – Although chronic respiratory diseases (CRDs) are the third leading cause of death globally, there remains a ‘mismatch’ between impact and action, said a group of global health leaders and experts on the sidelines of the 80th UN General Assembly. “There is a mismatch between the disease [impact] from CRD and the action against […] Continue reading -> UN Declaration on Noncommunicable Diseases Fails to Win Approval After US Foils Consensus 25/09/2025 Elaine Ruth Fletcher NEW YORK CITY – A painstakingly negotiated Political Declaration on Noncommunicable Diseases with overwhelming support from UN member states failed to win formal endorsement at a special High Level Session of the General Assembly (GA) Thursday – after the United States torpedoed its adoption by consensus. The last minute moves means that the draft declaration […] Continue reading -> A Problem Shared Is a Problem Halved: Why Cities Are Essential for Confronting the NCD Crisis 22/09/2025 Ariella Rojhani & Etienne Krug On 25 September, world leaders will gather at the United Nations for the Fourth High-Level Meeting on Noncommunicable Diseases (NCDs). It comes at a pivotal moment: funding for global health has plummeted, while NCDs like heart disease, cancer and diabetes continue to claim 75% of all lives lost worldwide. This amid recent efforts to water […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
UN Declaration on Noncommunicable Diseases Fails to Win Approval After US Foils Consensus 25/09/2025 Elaine Ruth Fletcher NEW YORK CITY – A painstakingly negotiated Political Declaration on Noncommunicable Diseases with overwhelming support from UN member states failed to win formal endorsement at a special High Level Session of the General Assembly (GA) Thursday – after the United States torpedoed its adoption by consensus. The last minute moves means that the draft declaration […] Continue reading -> A Problem Shared Is a Problem Halved: Why Cities Are Essential for Confronting the NCD Crisis 22/09/2025 Ariella Rojhani & Etienne Krug On 25 September, world leaders will gather at the United Nations for the Fourth High-Level Meeting on Noncommunicable Diseases (NCDs). It comes at a pivotal moment: funding for global health has plummeted, while NCDs like heart disease, cancer and diabetes continue to claim 75% of all lives lost worldwide. This amid recent efforts to water […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
A Problem Shared Is a Problem Halved: Why Cities Are Essential for Confronting the NCD Crisis 22/09/2025 Ariella Rojhani & Etienne Krug On 25 September, world leaders will gather at the United Nations for the Fourth High-Level Meeting on Noncommunicable Diseases (NCDs). It comes at a pivotal moment: funding for global health has plummeted, while NCDs like heart disease, cancer and diabetes continue to claim 75% of all lives lost worldwide. This amid recent efforts to water […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts